Literature DB >> 31267108

Gene therapy's next installment.

.   

Abstract

Mesh：

Year:  2019        PMID： 31267108     DOI： 10.1038/s41587-019-0194-z

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  8 in total

1.  Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion.

Authors:  Denis Horgan; Andres Metspalu; Marie-Christine Ouillade; Dimitrios Athanasiou; John Pasi; Oumeya Adjali; Patrick Harrison; Cedric Hermans; Giovanni Codacci-Pisanelli; Jasmina Koeva; Thomas Szucs; Viorica Cursaru; Ivica Belina; Chiara Bernini; Suijie Zhuang; Stephen McMahon; Draga Toncheva; Thomas Thum
Journal:  Biomed Hub       Date:  2020-12-03

Review 2.  Pulmonary gene delivery-Realities and possibilities.

Authors:  Uday K Baliga; David A Dean
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-12

3.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

Review 4.  Development of New Strategies Using Extracellular Vesicles Loaded with Exogenous Nucleic Acid.

Authors:  Nicola Salvatore Orefice
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

Review 5.  The impact of COVID-19 on the cell and gene therapies industry: disruptions, opportunities, and future prospects.

Authors:  Tingting Qiu; Yitong Wang; Shuyao Liang; Ru Han; Mondher Toumi
Journal:  Drug Discov Today       Date:  2021-04-20       Impact factor: 7.851

Review 6.  CRISPR-Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing.

Authors:  Irina Gostimskaya
Journal:  Biochemistry (Mosc)       Date:  2022-08       Impact factor: 2.824

Review 7.  Immune Response Mechanisms against AAV Vectors in Animal Models.

Authors:  Ashley T Martino; David M Markusic
Journal:  Mol Ther Methods Clin Dev       Date:  2019-12-25       Impact factor: 6.698

8.  Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy - current and future perspectives.

Authors:  Darnel Prakoso; Mitchel Tate; Miles J De Blasio; Rebecca H Ritchie
Journal:  Clin Sci (Lond)       Date:  2021-06-11       Impact factor: 6.124
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.